Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study

被引：0
|
作者：
Smolen, Josef S. [1 ,2 ]
van Vollenhoven, Ronald [3 ]
Kavanaugh, Arthur [4 ]
Strand, Vibeke [5 ]
Vencovsky, Jiri [6 ]
Schiff, Michael H. [7 ]
Landewe, Robert [8 ,9 ]
Haraoui, Boulos [10 ]
Walker, Susan [11 ]
van der Heijde, Desiree [12 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Hietzing Hosp, Vienna, Austria
[3] Karolinska Inst, Stockholm, Sweden
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Stanford Univ, Palo Alto, CA 94304 USA
[6] Charles Univ Prague, Dept Clin & Expt Rheumatol, Inst Rheumatol, Fac Med 1, Prague, Czech Republic
[7] Univ Colorado, Denver, CO 80202 USA
[8] Acad Med Ctr Amsterdam, Heerlen, Netherlands
[9] Atrium Med Ctr, Heerlen, Netherlands
[10] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[11] UCB Pharma, Raleigh, NC USA
[12] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2321
引用
收藏
页码：S988 / S989
页数：2
相关论文
共 50 条
  • [31] Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial
    Petersenn, S.
    Salgado, L. R.
    Schopohl, J.
    Portocarrero-Ortiz, L.
    Arnaldi, G.
    Lacroix, A.
    Scaroni, C.
    Ravichandran, S.
    Kandra, A.
    Biller, B. M. K.
    ENDOCRINE, 2017, 57 (01) : 156 - 165
  • [32] Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study
    Kameda, Hideto
    Nishida, Keiichiro
    Nanki, Toshihiro
    Watanabe, Akira
    Oshima, Yukiya
    Momohara, Shigeki
    MODERN RHEUMATOLOGY, 2023, 33 (03) : 460 - 471
  • [33] Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial
    S. Petersenn
    L. R. Salgado
    J. Schopohl
    L. Portocarrero-Ortiz
    G. Arnaldi
    A. Lacroix
    C. Scaroni
    S. Ravichandran
    A. Kandra
    B. M. K. Biller
    Endocrine, 2017, 57 : 156 - 165
  • [34] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [35] Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study
    Roy, Asim
    Ojile, Joseph
    Kram, Jerrold
    Olin, Jonathan
    Rosenberg, Russell
    Hudson, J. Douglas
    Bogan, Richard K.
    Charlesworth, Jonathan D.
    SLEEP, 2023, 46 (10)
  • [36] Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
    Ruperto, Nicolino
    Lovell, Daniel J.
    Cuttica, Ruben
    Woo, Patricia
    Meiorin, Silvia
    Wouters, Carine
    Silverman, Earl D.
    Balogh, Zsolt
    Henrickson, Michael
    Davidson, Joyce
    Foeldvari, Ivan
    Imundo, Lisa
    Simonini, Gabriele
    Oppermann, Joachim
    Xu, Stephen
    Shen, Yaung-Kaung
    Visvanathan, Sudha
    Fasanmade, Adedigbo
    Mendelsohn, Alan
    Martini, Alberto
    Giannini, Edward H.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 718 - 722
  • [37] Long-term efficacy & safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: Findings from an open-label treatment extension.
    Lovell, D. J.
    Ruperto, N.
    Cuttica, R.
    Woo, P.
    Espada, G.
    Wouters, C.
    Silverman, E. D.
    Balogh, Z.
    Henrickson, M.
    Davidson, J.
    Foeldvari, I.
    Imundo, L.
    Simonini, G.
    Oppermann, J.
    Shen, Y. K.
    Visvanathan, S.
    Fasanmade, A.
    Mendelsohn, A.
    Giannini, E. H.
    Martini, A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S632 - S632
  • [38] Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
    Jürgen Wollenhaupt
    Eun-Bong Lee
    Jeffrey R. Curtis
    Joel Silverfield
    Ketti Terry
    Koshika Soma
    Chris Mojcik
    Ryan DeMasi
    Sander Strengholt
    Kenneth Kwok
    Irina Lazariciu
    Lisy Wang
    Stanley Cohen
    Arthritis Research & Therapy, 21
  • [39] Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+Year Results of a 5-Year, Open-Label Extension Study
    Ashina, M.
    Goadsby, P. J.
    Reuter, U.
    Silberstein, S. D.
    Dodick, D. W.
    Chou, D. E.
    Klatt, J.
    Xue, F.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    HEADACHE, 2019, 59 : 25 - 25
  • [40] A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (final 5-year data)
    Klareskog, L
    Wajdula, J
    Pedersen, R
    Yeh, P
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 254 - 254
12345